Phase III trials of targeted anticancer therapies: redesigning the concept.
about
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test.Integrating biomarkers in colorectal cancer trials in the West and China.Model-Based Design of a Decision Tree for Treating HER2+ Cancers Based on Genetic and Protein Biomarkers
P2860
Phase III trials of targeted anticancer therapies: redesigning the concept.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Phase III trials of targeted anticancer therapies: redesigning the concept.
@en
type
label
Phase III trials of targeted anticancer therapies: redesigning the concept.
@en
prefLabel
Phase III trials of targeted anticancer therapies: redesigning the concept.
@en
P2093
P1476
Phase III trials of targeted anticancer therapies: redesigning the concept.
@en
P2093
Bostjan Seruga
Francisco Vera-Badillo
Ian F Tannock
P304
P356
10.1158/1078-0432.CCR-13-1222
P407
P577
2013-07-23T00:00:00Z